Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

BACKGROUND: Outcome of sirolimus-eluting stent (SES) in patients treated with an antivitamin K (VKA) agent before the PCI procedure is unknown. METHODS: A total of 7651 patients were selected among 15,147 recipients of SES, included in the worldwide e-SELECT registry, only from those centers which i...

Полное описание

Библиографические подробности
Главные авторы: Sabaté, M, Brugaletta, S, Abizaid, A, Banning, A, Bartorelli, A, Džavík, V, Ellis, S, Holmes, D, Gao, R, Jeong, M, Legrand, V, Neumann, F, Nyakern, M, Spaulding, C, Stoll, H, Worthley, S, Urban, P
Формат: Journal article
Язык:English
Опубликовано: 2013